Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

NYSE:DGX

Quest Diagnostics Incorporated

Last Close

137.38

06/05 20:00

Market Cap

15.07B

Beta: 0.94

Volume Today

716.70K

Avg: 1.14M

PE Ratio

16.23

PFCF: 23.35

Dividend Yield

2.29%

Payout:36.18%

Filings Not Available